{
  "id": "map_1748",
  "title": "Inmunizaciones en Adultos Mayores y Poblaciones Especiales\\N(**M. Paz Iturrieta M.**, H. S√≥tero del R√≠o)",
  "specialty": "Infectolog√≠a",
  "tag": "üìã Gu√≠a Cl√≠nica",
  "node_count": 196,
  "root": {
    "text": "Inmunizaciones en Adultos Mayores y Poblaciones Especiales\\N(**M. Paz Iturrieta M.**, H. S√≥tero del R√≠o)",
    "children": [
      {
        "text": "- Importancia de\\Nla Vacunaci√≥n",
        "children": [
          {
            "text": "‚Ä∫ Intervenci√≥n de alto\\Nimpacto en salud mundial",
            "children": [
              {
                "text": "‚óä >150 millones de vidas salvadas [URL: www. who. int/es/news/item/24-04-2024-global-immunization-efforts-have-saved-at-least-154-million-lives-over-the-past-50-years]",
                "children": []
              },
              {
                "text": "‚óä Evitaci√≥n de >20 millones secuelados de polio [URL: www.who. int/es/news/item/24-04-2024-global-immunization-efforts-have-saved-at-least-154-million-lives-over-the-past-50-years]",
                "children": []
              }
            ]
          },
          {
            "text": "‚Ä∫ Erradicaci√≥n y control\\Nde enfermedades",
            "children": [
              {
                "text": "‚óä Viruela humana, polio, coqueluche,\\Nneumococo, Hib, **SARS-CoV-2**",
                "children": []
              }
            ]
          },
          {
            "text": "‚Ä∫ ‚òÖ P√©rdida de oportunidad de vacunaci√≥n en poblaci√≥n adulta",
            "children": []
          }
        ]
      },
      {
        "text": "- Generalidades\\Nen Vacunas",
        "children": [
          {
            "text": "‚Ä∫ Tipos de Vacunas\\NBacterianas",
            "children": [
              {
                "text": "‚óä Vivas atenuadas: BCG, Fiebre tifoidea oral, C√≥lera oral",
                "children": []
              },
              {
                "text": "‚óä Inactivadas C√©lulas enteras: Pertussis, Fiebre tifoidea parenteral, C√≥lera parenteral",
                "children": []
              },
              {
                "text": "‚óä Inactivadas Subunidades: Pertussis acelular",
                "children": []
              },
              {
                "text": "‚óä Inactivadas Toxoides: Difteria, T√©tanos",
                "children": []
              },
              {
                "text": "‚óä Inactivadas Polisac√°ridos: Meningococo, ‚òÖ**Neumococo 23 valente**",
                "children": []
              },
              {
                "text": "‚óä Inactivadas Conjugadas: ‚òÖ**Neumococo (7, 10, 13, 20 valente)**, Hib, Meningococo",
                "children": []
              }
            ]
          },
          {
            "text": "‚Ä∫ Tipos de Vacunas\\NVirales",
            "children": [
              {
                "text": "‚óä Vivas atenuadas: Polio oral, Influenza intranasal, Sarampi√≥n, Rubeola, Parotiditis, Varicela, Zoster (‚òÖ**Zostavax**), Fiebre amarilla",
                "children": []
              },
              {
                "text": "‚óä Inactivadas Virus enteros: Polio parenteral, Influenza, ‚òÖ**Hepatitis A**, Rabia, Encefalitis japonesa",
                "children": []
              },
              {
                "text": "‚óä Inactivadas Subunidades: Influenza, ‚òÖ**Hepatitis B**, Virus Papiloma Humano (VPH)",
                "children": []
              },
              {
                "text": "‚óä mRNA: ‚òÖ**SARS-CoV-2**",
                "children": []
              }
            ]
          },
          {
            "text": "‚Ä∫ Contraindicaciones\\N(Pocas)",
            "children": [
              {
                "text": "‚óä Fiebre (transitoria): Todas las vacunas",
                "children": []
              },
              {
                "text": "‚óä Anafilaxia a dosis previa: Vacuna espec√≠fica",
                "children": []
              },
              {
                "text": "‚óä Vacunas Vivas\\NAtenuadas:",
                "children": [
                  {
                    "text": "‚Ä¢ Contraindicadas en: Inmunosuprimidos (o previo a IS), Embarazo, >65 a√±os (algunas)",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Ejemplos Vivas: BCG, C√≥lera oral, Polio oral, SRP, VVZ (Varicela-Zoster), Fiebre Amarilla",
                    "children": []
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "text": "- Vacunas en\\NSituaciones Especiales",
        "children": [
          {
            "text": "‚Ä∫ ‚òÖ Diabetes Mellitus (DM)",
            "children": [
              {
                "text": "‚óä Influenza y COVID: Anual (Observaci√≥n: 30% hospitalizados Flu son DM [**CDC 2024**])",
                "children": []
              },
              {
                "text": "‚óä ‚òÖ**S. pneumoniae**: 13v + 23v (Esquema: 0-2 meses) (Observaci√≥n: Mayor riesgo neumon√≠a complicada [**Kornum JB 2007**])",
                "children": []
              },
              {
                "text": "‚óä H. influenzae tipo b (Hib): 1 dosis",
                "children": []
              },
              {
                "text": "‚óä Meningo ACWY (Nimenrix): 1 dosis (Observaci√≥n: DM como factor riesgo meningitis [**Asori M 2022**])",
                "children": []
              },
              {
                "text": "‚óä ‚òÖ**Hepatitis B**: 0-1-6 meses (si posible Hemodi√°lisis - HD)",
                "children": []
              }
            ]
          },
          {
            "text": "‚Ä∫ Enfermedades Card√≠acas\\N(Falla card√≠aca,\\NMiocardiopat√≠a, HTA en tto)",
            "children": [
              {
                "text": "‚óä Influenza y COVID: Anual",
                "children": []
              },
              {
                "text": "‚óä ‚òÖ**S. pneumoniae**: 13v + 23v (Esquema: 0-2 meses)",
                "children": []
              }
            ]
          },
          {
            "text": "‚Ä∫ Enfermedad Hep√°tica Cr√≥nica\\N(Da√±o hep√°tico cr√≥nico)",
            "children": [
              {
                "text": "‚óä Influenza y COVID: Anual",
                "children": []
              },
              {
                "text": "‚óä ‚òÖ**S. pneumoniae**: 13v + 23v (Esquema: 0-2 meses)",
                "children": []
              },
              {
                "text": "‚óä ‚òÖ**Hepatitis A**: 0-6 meses",
                "children": []
              },
              {
                "text": "‚óä ‚òÖ**Hepatitis B**: 0-1-6 meses",
                "children": []
              },
              {
                "text": "‚óä Meningo ACWY (Nimenrix): 1 dosis",
                "children": []
              }
            ]
          },
          {
            "text": "‚Ä∫ Enfermedades Renales\\N(ERC, S√≠ndrome Nefr√≥tico)",
            "children": [
              {
                "text": "‚óä Influenza y COVID: Anual",
                "children": []
              },
              {
                "text": "‚óä ‚òÖ**S. pneumoniae**: 13v + 23v (Esquema: 0-2 meses + refuerzo Neumo23 a los 5 a√±os)",
                "children": []
              },
              {
                "text": "‚óä ‚òÖ**Hepatitis B**:",
                "children": [
                  {
                    "text": "‚Ä¢ ERC: Dosis doble (20 ug) 0-1-6 meses",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ HD: Dosis x4 (40 ug) 0-1-2-6 meses (refuerzo si vacunado previo)",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ *No requiere formulario especial*",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚óä Meningo ACWY (Nimenrix): 1 dosis",
                "children": []
              }
            ]
          },
          {
            "text": "‚Ä∫ Enfermedades Respiratorias\\N(EPOC, Asma persistente,\\NBronquiectasias, etc.)",
            "children": [
              {
                "text": "‚óä Influenza y COVID: Anual",
                "children": []
              },
              {
                "text": "‚óä ‚òÖ**S. pneumoniae**: 13v + 23v (Esquema: 0-2 meses)",
                "children": []
              },
              {
                "text": "‚óä Haemophilus influenzae tipo b (Hib): 1 dosis",
                "children": []
              },
              {
                "text": "‚óä ‚òÖ**Hepatitis A**: 0-6 meses (S√≥lo Fibrosis Qu√≠stica - FQ)",
                "children": []
              },
              {
                "text": "‚óä ‚òÖ**Hepatitis B**: 0-1-6 meses (S√≥lo FQ)",
                "children": []
              }
            ]
          },
          {
            "text": "‚Ä∫ Enfermedades Neurol√≥gicas (Par√°lisis cerebral, ACV\\Nsecuelado, Postraci√≥n, F√≠stula LCR, Implante coclear)",
            "children": [
              {
                "text": "‚óä Influenza y COVID: Anual",
                "children": []
              },
              {
                "text": "‚óä ‚òÖ**S. pneumoniae**: 13v + 23v (Esquema: 0-2 meses)",
                "children": []
              },
              {
                "text": "‚óä H. influenzae tipo b (Hib): 1 dosis",
                "children": []
              },
              {
                "text": "‚óä Meningo ACWY (Nimenrix): 1 dosis (S√≥lo F√≠stula LCR / Implante coclear)",
                "children": []
              }
            ]
          },
          {
            "text": "‚Ä∫ Usuarios de Corticoides\\N(Prednisona ‚â•20 mg/d√≠a x ‚â•7 d√≠as)",
            "children": [
              {
                "text": "‚óä Vacunas Inactivadas (DTPa, Neumo 13v+23v, Hib, Hep A, Hep B, VPH, Influenza): Posponer 1 mes post-corticoterapia",
                "children": []
              },
              {
                "text": "‚óä Vacunas Atenuadas (Varicela): Posponer 1-3 meses post-corticoterapia (si sin antecedente enfermedad)",
                "children": []
              }
            ]
          },
          {
            "text": "‚Ä∫ Terapias Biol√≥gicas\\N(Inmunosupresi√≥n farmacol√≥gica)",
            "children": [
              {
                "text": "‚óä Influenza y COVID: Anual",
                "children": []
              },
              {
                "text": "‚óä ‚òÖ**S. pneumoniae**: 13v + 23v",
                "children": []
              },
              {
                "text": "‚óä Meningo ACWY: 2 dosis",
                "children": []
              },
              {
                "text": "‚óä H. influenzae b (Hib): 1 dosis",
                "children": []
              },
              {
                "text": "‚óä VHA (Hep A): 0-6 meses (regiones alta endemia / viajeros)",
                "children": []
              },
              {
                "text": "‚óä ‚òÖ**VHB (Hep B)**: 0-1-6 meses",
                "children": []
              },
              {
                "text": "‚óä VPH: 0-2-6 meses",
                "children": []
              },
              {
                "text": "‚óä DTPa",
                "children": []
              },
              {
                "text": "‚óä *Administrar ‚â•3 semanas ANTES de iniciar terapia IS*",
                "children": []
              }
            ]
          },
          {
            "text": "‚Ä∫ Vacunas por ‚òÖ**GES**\\N(*No requieren formulario\\Nespecial*)",
            "children": [
              {
                "text": "‚óä Infecci√≥n cr√≥nica Hep B: ‚òÖ**Hepatitis A** (0-6 m)",
                "children": []
              },
              {
                "text": "‚óä Leucemia >15 a√±os: ‚òÖ**Neumo 13v+23v** (0-2 m)",
                "children": []
              },
              {
                "text": "‚óä Linfoma >15 a√±os: ‚òÖ**Neumo 13v+23v** (0-2 m)",
                "children": []
              }
            ]
          },
          {
            "text": "‚Ä∫ Vacunas por ‚òÖ**Ley Ricarte Soto**\\N(*No requieren formulario especial*)",
            "children": [
              {
                "text": "‚óä AR refractaria, AP: ‚òÖ**Neumo 13v+23v** (0-2 m), Influenza",
                "children": []
              },
              {
                "text": "‚óä Colitis Ulcerosa: ‚òÖ**Neumo 13v+23v** (0-2 m), ‚òÖ**Hep B** (0-1-6 m), Influenza",
                "children": []
              },
              {
                "text": "‚óä Enf. Crohn grave: ‚òÖ**Neumo 13v+23v** (0-2 m), VPH (<26a, 0-2-6 m), Influenza",
                "children": []
              },
              {
                "text": "‚óä Hipoacusia sensorineural postlocutiva: ‚òÖ**Neumo 13v+23v** (0-2 m)",
                "children": []
              },
              {
                "text": "‚óä Esclerosis M√∫ltiple: ‚òÖ**Neumo 13v+23v** (0-2 m), ‚òÖ**Hep B** (0-1-6 m), Influenza",
                "children": []
              },
              {
                "text": "‚óä Lupus: ‚òÖ**Neumo 13v+23v** (0-2 m), Influenza",
                "children": []
              }
            ]
          },
          {
            "text": "‚Ä∫ Candidatos a\\NEsplenectom√≠a",
            "children": [
              {
                "text": "‚óä ‚òÖ**S. pneumoniae**: 13v + 23v (Esquema: 0-2 meses, iniciar 2 sem pre-qx). Refuerzo Neumo23 a 5 a√±os.",
                "children": []
              },
              {
                "text": "‚óä Haemophilus influenzae tipo b (Hib): 1 dosis",
                "children": []
              },
              {
                "text": "‚óä Meningo ACWY (Nimenrix): 2 dosis (Esquema: 0-2 meses). Revacunar 3-5 a√±os.",
                "children": []
              },
              {
                "text": "‚óä Influenza y COVID: Anual",
                "children": []
              },
              {
                "text": "‚óä *Si no vacunado pre-qx: vacunar ‚â•3 semanas post-qx*",
                "children": []
              }
            ]
          },
          {
            "text": "‚Ä∫ Personas Viviendo con VIH\\N(PVVIH)",
            "children": [
              {
                "text": "‚óä ‚òÖ**S. pneumoniae**: 13v + 23v (Esquema: 0-2 meses). Refuerzo Neumo23 en 5 a√±os (1 vez).",
                "children": []
              },
              {
                "text": "‚óä N. meningitidis ACWY (Nimenrix): 2 dosis (Esquema: 0-2 meses). Repetir en 3-5 a√±os.",
                "children": []
              },
              {
                "text": "‚óä ‚òÖ**Hepatitis A**: 2 dosis (0-6 meses). Hasta 40 a√±os (orden ministerial).",
                "children": []
              },
              {
                "text": "‚óä ‚òÖ**Hepatitis B**: 3 dosis (0-1-6 meses). S√≥lo seronegativos. (*No requiere formulario especial*)",
                "children": []
              },
              {
                "text": "‚óä VPH: 3 dosis (0-2-6 meses). Hasta 25 a√±os 11 meses (o >26a VPH refractario).",
                "children": []
              },
              {
                "text": "‚óä Anti-zoster (Recomendada): 1 dosis. >50 a√±os y CD4>500 (No disponible PNI).",
                "children": []
              },
              {
                "text": "‚óä Influenza y COVID: Anual",
                "children": []
              },
              {
                "text": "‚óä Ofrecer Mpox: 2 dosis",
                "children": []
              }
            ]
          },
          {
            "text": "‚Ä∫ Pacientes con C√°ncer\\N(Hemato-oncol√≥gico o S√≥lido)",
            "children": [
              {
                "text": "‚óä ‚òÖ**S. pneumoniae**: 13v + 23v (Esquema: 0-2 meses). En fase de remisi√≥n.",
                "children": []
              },
              {
                "text": "‚óä ‚òÖ**Hepatitis B**: 3 dosis (0-1-6 meses). En fase de remisi√≥n.",
                "children": []
              },
              {
                "text": "‚óä Anti-zoster (Recomendada): 1 dosis. A 6 meses de finalizada QT (No disponible PNI).",
                "children": []
              },
              {
                "text": "‚óä Influenza y COVID: Anual",
                "children": []
              }
            ]
          },
          {
            "text": "‚Ä∫ Candidatos a Trasplante √ìrgano S√≥lido\\N(Pre-Trasplante)",
            "children": [
              {
                "text": "‚óä ‚òÖ**Hepatitis A**: ‚â•1 mes pre-Tx. Esquema 0-6m / acelerado 0-4m. (No si antecedente Hep A).",
                "children": []
              },
              {
                "text": "‚óä ‚òÖ**Hepatitis B**: ‚â•1 mes pre-Tx. Esquema 0-1-6m / acelerado 0-7-21d o 0-14-60d + refuerzo al a√±o. (Requiere HBsAg (-)).",
                "children": []
              },
              {
                "text": "‚óä ‚òÖ**S. pneumoniae**: 13v+23v: M√°x 2 sem pre-Tx. Esquema 0 (13v) y 2m (23v).",
                "children": []
              },
              {
                "text": "‚óä Meningoc√≥cica ACWY (Nimenrix): M√°x 2 sem pre-Tx. 1 dosis.",
                "children": []
              },
              {
                "text": "‚óä Hib: M√°x 2 sem pre-Tx. 1 dosis.",
                "children": []
              },
              {
                "text": "‚óä Influenza y COVID: Anual.",
                "children": []
              }
            ]
          },
          {
            "text": "‚Ä∫ Vacunas Post-Trasplante\\N√ìrgano S√≥lido",
            "children": [
              {
                "text": "‚óä 6 meses post-Tx:",
                "children": [
                  {
                    "text": "‚Ä¢ Influenza: Anual",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ ‚òÖ**S. pneumoniae 13v+23v**: 0-2 meses (si no recibi√≥ pre-Tx)",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚óä 12 meses post-Tx:",
                "children": [
                  {
                    "text": "‚Ä¢ ‚òÖ**Hepatitis B**: 1 dosis refuerzo (con HBsAg negativo)",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚óä General:",
                "children": [
                  {
                    "text": "‚Ä¢ Influenza y COVID: Anual",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Actualizar ‚òÖ**RNI** (Registro Nacional Inmunizaciones): seg√∫n estado IS (cuidado vacunas vivas)",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "‚Ä∫ Vacunas Post Trasplante\\NHematopoy√©tico (TPH)",
            "children": [
              {
                "text": "‚óä Neumoc√≥cica conjugada 13v: 3 dosis (Mes 6, 8, 10 post-TPH)",
                "children": []
              },
              {
                "text": "‚óä Neumoc√≥cica polisac√°rida 23v: 1 dosis (Mes 12 post-TPH, ‚â•2m post 13v)",
                "children": []
              },
              {
                "text": "‚óä dTPa: 3 dosis (Mes 6, 8, 10 post-TPH)",
                "children": []
              },
              {
                "text": "‚óä ‚òÖ**Hepatitis B**: 3 dosis (Mes 6, 7, 12 post-TPH)",
                "children": []
              },
              {
                "text": "‚óä Polio inactivada: 3 dosis (Mes 6, 8, 10 post-TPH)",
                "children": []
              },
              {
                "text": "‚óä Haemophilus influenzae b (Hib): 3 dosis (Mes 6, 7, 8 post-TPH)",
                "children": []
              },
              {
                "text": "‚óä N. meningitidis ACWY: 2 dosis (Mes 12, 14 post-TPH)",
                "children": []
              },
              {
                "text": "‚óä ‚òÖ**Hepatitis A**: 2 dosis (Mes 6, 12 post-TPH)",
                "children": []
              },
              {
                "text": "‚óä VPH (<26 a√±os): 3 dosis (Mes 12, 14, 18 post-TPH)",
                "children": []
              },
              {
                "text": "‚óä Influenza: Anual (Estacional)",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "text": "- Vacunas en\\NAdulto Mayor (AM)",
        "children": [
          {
            "text": "‚Ä∫ Situaci√≥n Epidemiol√≥gica\\NChile",
            "children": [
              {
                "text": "‚óä Envejecimiento poblacional avanzado",
                "children": []
              },
              {
                "text": "‚óä Esperanza de vida: **2019** (H: 77.9, M: 83.4) ‚Üí Proyecci√≥n **2035** (H: 80.9, M: 86.0)",
                "children": []
              },
              {
                "text": "‚óä Poblaci√≥n ‚â•65 a√±os: **2019** (11.9%) ‚Üí Proyecci√≥n **2035** (18.9%)",
                "children": []
              }
            ]
          },
          {
            "text": "‚Ä∫ Particularidades y\\NDesaf√≠os",
            "children": [
              {
                "text": "‚óä ‚òÖ**Inmunosenescencia**",
                "children": []
              },
              {
                "text": "‚óä ‚òÖ**Inflammaging**\\N(Inflamaci√≥n cr√≥nica)",
                "children": [
                  {
                    "text": "‚óä < Respuesta a vacunaci√≥n (dise√±adas para j√≥venes)",
                    "children": []
                  },
                  {
                    "text": "‚óä Opini√≥n personal: Poca cultura de indicaci√≥n en m√©dicos de adulto",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "‚Ä∫ Vacunas Disponibles/Recomendadas\\Nen Chile (PNI **2024**)",
            "children": [
              {
                "text": "‚óä ‚â• 60 a√±os: ‚òÖ**Influenza**, ‚òÖ**COVID-19** (Anual)",
                "children": []
              },
              {
                "text": "‚óä ‚â• 65 a√±os: ‚òÖ**Neumoc√≥cica 23 valente** (√önica dosis PNI)",
                "children": []
              },
              {
                "text": "‚óä *Verificar calendario completo PNI **2024***",
                "children": []
              }
            ]
          },
          {
            "text": "‚Ä∫ Varicela Z√≥ster\\N(VVZ)",
            "children": [
              {
                "text": "‚óä Reactivaci√≥n VVZ: 25-35% a lo largo de la vida, > incidencia en >80 a√±os",
                "children": []
              },
              {
                "text": "‚óä Complicaciones: Neuralgia post-herp√©tica (NPH), sobreinfecci√≥n, neumon√≠a, encefalitis",
                "children": []
              },
              {
                "text": "‚óä Vacunas\\Ndisponibles:",
                "children": [
                  {
                    "text": "‚Ä¢ ‚òÖ**Zostavax**: Viva atenuada, 1 dosis SC. Disponible privado Chile (~$114.000). (Contraindicada IS/embarazo).",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ ‚òÖ**Shingrix**: Inactivada recombinante, 2 dosis IM (0, 2-6 meses). No disponible Chile (momento de la presentaci√≥n). (Costo ~200 USD/dosis).",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "‚Ä∫ Virus Respiratorio Sincicial\\N(VRS)",
            "children": [
              {
                "text": "‚óä Afecta > a IS y AM (principal causa viral NAC)",
                "children": []
              },
              {
                "text": "‚óä Vacunas aprobadas FDA\\N(>60 a√±os, 1 dosis):",
                "children": [
                  {
                    "text": "‚Ä¢ ‚òÖ**Arexvy**: Inactivada adyuvantada. Eficacia 82%. Protecci√≥n 2 a√±os. Ingresando a Chile.",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ ‚òÖ**Abrysvo**: Inactivada adyuvantada. Eficacia 86%. Protecci√≥n 2 a√±os. Aprobada embarazadas.",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ mResvia: mRNA. Eficacia 50%. Protecci√≥n 1 a√±o.",
                    "children": []
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "text": "- Datos Pr√°cticos y\\NProceso Administrativo",
        "children": [
          {
            "text": "‚Ä∫ Recomendaciones\\NMinisteriales (**MINSAL**)",
            "children": [
              {
                "text": "‚óä Gu√≠a \"Vacunaci√≥n de pacientes con necesidades especiales\" (**2018**)",
                "children": []
              },
              {
                "text": "‚óä Posible actualizaci√≥n **2024**",
                "children": []
              },
              {
                "text": "‚óä Refuerzo indicaciones ORD B27/N¬∞ 2000 (**29 SEP 2023**)",
                "children": []
              }
            ]
          },
          {
            "text": "‚Ä∫ Solicitud Vacunas Especiales\\N(No GES/LRS/PNI directo)",
            "children": [
              {
                "text": "‚óä Indicaci√≥n m√©dica seg√∫n **MINSAL**",
                "children": []
              },
              {
                "text": "‚óä Proceso:",
                "children": [
                  {
                    "text": "‚Ä¢ 1. Receta m√©dica (Dx, meds IS, dosis vacunas)",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ 2. ‚òÖ**Formulario Vacunas Especiales** (Buscar en Google)",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ 3. Posible epicrisis/informe m√©dico",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚óä Flujo: Solicitud (vacunatorio) ‚Üí Aprobaci√≥n (**SEREMI**)\\N‚Üí Env√≠o vacuna (puede tardar meses)",
                "children": []
              },
              {
                "text": "‚óä Incluye pacientes sistema p√∫blico y privado",
                "children": []
              }
            ]
          },
          {
            "text": "‚Ä∫ ‚òÖ**Registro Nacional de\\NInmunizaciones (RNI)**",
            "children": [
              {
                "text": "‚óä Accesible en vacunatorios para verificar historial",
                "children": []
              },
              {
                "text": "‚óä *En caso de duda, mejor indicar*",
                "children": []
              }
            ]
          },
          {
            "text": "‚Ä∫ Orden Neumococo:",
            "children": [
              {
                "text": "‚óä Ideal: Prevenar 13 (13v) ‚Üí esperar 8 semanas (2 meses) ‚Üí Neumo 23 (23v)",
                "children": []
              },
              {
                "text": "‚óä Si Neumo23 primero ‚Üí esperar 1 a√±o ‚Üí Prevenar 13",
                "children": []
              }
            ]
          },
          {
            "text": "‚Ä∫ Proceso en Hospital S√≥tero del R√≠o (HSR)",
            "children": [
              {
                "text": "‚óä Indicaci√≥n en ‚òÖ**RCE**\\N(Registro Cl√≠nico Electr√≥nico)",
                "children": [
                  {
                    "text": "‚Ä¢ Pesta√±a \"Procedimientos\" ‚Üí \"Vacunas Especiales\"",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Indicar diagn√≥sticos (puede ser en \"observaciones anexas\")",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Imprimir solicitud",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚óä Paciente debe ir a Vacunatorio\\N(Infectolog√≠a Pedi√°trica, CDT) con la orden",
                "children": []
              },
              {
                "text": "‚óä Administraci√≥n: Inmediata (si disponible) o\\Nesperar llamado post-autorizaci√≥n **SEREMI**",
                "children": []
              }
            ]
          },
          {
            "text": "‚Ä∫ Seguridad y\\NComunicaci√≥n",
            "children": [
              {
                "text": "‚óä Vacunas seguras (usadas en ni√±os PNI Chile)",
                "children": []
              },
              {
                "text": "‚óä Oportunidad: Alto costo, previenen hospitalizaci√≥n/muerte",
                "children": []
              }
            ]
          },
          {
            "text": "‚Ä∫ ‚òÖ**ESAVI** (Eventos Supuestamente\\NAtribuibles a Vacunaci√≥n e Inmunizaci√≥n)",
            "children": [
              {
                "text": "‚óä Notificaci√≥n obligatoria (investigaci√≥n)",
                "children": []
              },
              {
                "text": "‚óä D√≥nde notificar: https://svi.ispch.gob. cl/isp/index o esavi@ispch.cl",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "text": "- Mensajes Finales",
        "children": [
          {
            "text": "‚Ä∫ Alto impacto vacunas en salud p√∫blica e individual (esp. AM)",
            "children": []
          },
          {
            "text": "‚Ä∫ ‚òÖNo perder oportunidad de vacunaci√≥n",
            "children": []
          },
          {
            "text": "‚Ä∫ Informaci√≥n sobre vacunas especiales accesible",
            "children": []
          },
          {
            "text": "‚Ä∫ ‚òÖCoordinar estrategias de vacunaci√≥n con equipo (m√©dico, enfermer√≠a, vacunatorios)",
            "children": []
          }
        ]
      }
    ]
  },
  "related_maps": [
    {
      "id": "map_1633",
      "title": "ACV: ESCALAS DE UTILIDAD CL√çNICA"
    },
    {
      "id": "map_1673",
      "title": "DAPA-CKD (2020)\\NDapagliflozin And Prevention\\Nof Adverse outcomes in CKD\\N\\N‚≠ê iSGLT2 protege ri√±√≥n\\NINCLUSO SIN DIABETES\\N(Extiende beneficio a ERC no-DM)"
    },
    {
      "id": "map_1674",
      "title": "CREDENCE (2019)\\NCanagliflozin and Renal Events in Diabetes\\N\\nCanagliflozina reduce progresion ERC\\ny eventos CV en DM2 con nefropatia\\nNNTH 22 para outcome renal"
    },
    {
      "id": "map_1689",
      "title": "SPRINTT (2021)\\NSarcopenia and Physical\\NFragility in Older People:\\NMulti-component Treatment\\N\\n‚≠ê Ejercicio + nutrici√≥n reduce\\ndiscapacidad en fragilidad f√≠sica\\ncon sarcopenia"
    },
    {
      "id": "map_1640",
      "title": "Aciclovir (ACV) versus Valaciclovir (VACV)"
    }
  ],
  "source_file": "Presentacion. Inmunizaciones en Adultos Mayores y Poblaciones Especiales-2025.smmx",
  "created": "2026-02-07T15:42:55.115133"
}